Nektar Therapeutics Announces Strategic Reprioritization and

-- Pipeline focus will prioritize programs in immunology, including REZPEG and several immunology research programs -- -- Development of NKTR-255 in diffuse...

Related Keywords

Alabama , United States , Stanford University , California , San Francisco , American , Eric Lawrence Simpson , Kevin Brodbeck , Jillian Thomsen , David Rosen , Vivian Wu , Howardw Robin , Mary Tagliaferri , Sandra Gardiner , Eli Lilly , Brian Kotzin , Ken Franke , American Academy Of Dermatology , Merck Kga , Exchange Commission On , Fred Hutchinson Cancer Center , Biologics Development Manufacturing , Nektar Therapeutics , Merck Kgaa , San Francisco Based , Annual Meeting , Medley Study , Colony Stimulating Factor , Chief Medical Officer , Chief Development Officer , Chief Medical , Chief Financial Officer , Technical Operations , Biologics Development , Call Details , Announce First Quarter , Chief Executive Officer , Home Page , Nektar Earnings Call , Hutchinson Cancer Center , Annual Report , Exchange Commission ,